Terpin is a p-menthane monoterpenoid.

Kajiichigoside F1 shows haemolytic and in vitro antiviral activity; it also exhibits in vivo hepatoprotective effects, it can inhibit d-GalN-induced cytotoxicity in primary cultured mouse hepatocytes(IC50=14.1uM). Kajiichigoside F1 shows antiinflammatory/antinociceptive action in acetic acid-induced writhing and hot plate testing and in a carrageenan-induced paw edema model in mice and rats.

Procyanidin C1 has anti-inflammatory effects, can inhibit IKKb activity in vitro and reduce the LPS-induced production of ROS, thus, it exerts the anti-inflammatory effects by inhibiting ERK1/2 and IKKb activity. Procyanidin C1 could be useful as a lead compound to develop inhibitors of cancer metastasis and other diseases related to epithelial-to-mesenchymal transition (EMT). Procyanidin C1 may represent a novel and potentially therapeutically relevant compound for the treatment of cardiovascular diseases, it -induced vasorelaxation is associated with the activation of the calcium-dependent NO/cGMP pathway, involving potassium channel activation. Procyanidin C1 is a proanthocyanidin consisting of three ()-epicatechin units joined by two successive (4beta8)-linkages. It has a role as an antioxidant, a metabolite, an EC 1.17.3.2 (xanthine oxidase) inhibitor, a lipoxygenase inhibitor, an anti-inflammatory agent and an EC 3.2.1.20 (alpha-glucosidase) inhibitor. It is a polyphenol, a proanthocyanidin and a hydroxyflavan. It is functionally related to a (-)-epicatechin.

(-)-epitaxifolin is a taxifolin that has (2R,3S)-configuration. It has a role as a metabolite. It is an enantiomer of a (+)-epitaxifolin.

Medicagenic acid, the factor responsible for hemolytic activity of lucerne saponins.Medicagenic acid derivatives exhibit potent fungistatic effects against several plant pathogens and human dermatophytes.

Epifriedelanol has antitumor activity, it can reduce cellular senescence in human primary cells and may be used to develop dietary supplements or cosmetics that modulate tissue aging or aging-associated diseases. Epifriedelanol exhibits significant inhibition of NF-kappa B, it may be used to treat asthma.